Founded in 2013, Jecho Labs is a research and development company focusing on bringing new treatments to more patients to fight cancers and infections diseases. We specialize in innovative therapeutic biologics within a wide spectrum of unique research and development domains. Our pipeline drug candidates include antibodies, cytokines, oncolytic viruses and other biological molecules and agents.
Pipelines
Oncology
JL15003 – Phase I trial (GBM)*
JL18001 – IND submission (ALL)*
JL19001 – IND submission (multiple cancers)
Infectious Diseases
JL18008 – IND submission (HIV)*#
JL20001 – IND approved (COVID-19)*
JLE047 – IND approved (COVID-19)*
Others
JL14001 – Phase I trial (Anemia)*
JL14002 – Phase III trial (AMD)*
Frederick's Top 50 Workplace and Top 50 Innovators
Join Us
Jecho Labs is an equal opportunity employer. We celebrate diversity and are committed to creating an inclusive environment for all employees. Jecho Labs offers a competitive salary and excellent benefits package, including health insurance, dental/vision insurance, short-term and long-term disability insurance, and 401(k) retirement plan.